Publications by authors named "Sarah Bhonkar"
Article Synopsis
- The study aimed to investigate sex-based differences in outcomes for patients with acute ischemic stroke (AIS) who underwent recanalization treatments at a medical center in Israel between 2011 and 2020.
- Researchers analyzed data from 811 patients, finding that women had higher mean age and more severe conditions compared to men, but both sexes had similar outcomes despite women presenting with more risk factors.
- The study concluded that while women had more severe symptoms, there were no significant differences in outcomes between sexes, highlighting the importance of managing risk factors to reduce stroke-related issues for both genders.
Article Synopsis
- The study analyzed 100 adult patients with Guillain-Barré syndrome (GBS) from 2006 to 2018, finding that a significant 46.8% exhibited an axonal pattern in their EMG results.
- A majority (58%) of those who initially presented with mild symptoms experienced a deterioration in their condition, with several losing the ability to walk independently.
- The research concluded that a higher incidence of axonal GBS was observed in Israel compared to European and North American cohorts, and emphasized the need for prompt treatment following a GBS diagnosis due to the disease's progressive nature.
Article Synopsis
- A study was conducted to evaluate the safety and efficacy of thrombolytic treatment (IVTPA) in patients with wake-up acute ischemic strokes, based on their normal non-contrast brain CT scans.* -
- The retrospective analysis included 306 patients, with 27 having wake-up strokes; outcomes such as discharge rates and in-hospital mortality were comparable between the two groups.* -
- The results suggest it's safe to administer IVTPA to wake-up stroke patients, proposing that treatment eligibility might be extended beyond the usual 4.5 hours for those with normal brain scans after a witnessed stroke.*
Background: Use of TPA to treat patients with acute ischemic stroke was introduced in Assaf Harofeh Medical Center (AHMC) in Israel in November 2007 initially with strict adherence to the inclusion/exclusion criteria of the pivotal NINDS TPA studies published in 1995. The treatment window was expanded in 2010 to 4.5h following the results of ECASS-III.
View Article and Find Full Text PDF